Literature DB >> 14297704

PREVENTION OF HYPERURICEMIA IN LEUKEMIA AND LYMPHOMA: USE OF ALOPURINOL, A XANTHINE OXIDASE INHIBITOR.

I H KRAKOFF, R L MEYER.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANTINEOPLASTIC AGENTS; BLOOD; BLOOD UREA NITROGEN; DRUG THERAPY; GERIATRICS; LEUKEMIA; LEUKEMIA, MYELOCYTIC; LYMPHOSARCOMA; METABOLISM; NITROGEN; PYRIMIDINES; SARCOMA, RETICULUM CELL; UREA; URIC ACID; URICOSURIC AGENTS; URINE; XANTHINE OXIDASE

Mesh：

Substances：

Year:  1965        PMID： 14297704     DOI： 10.1001/jama.1965.03090010007001

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

1.  Tracheostomy: its management and alternatives.

Authors:  R M McClelland
Journal:  Proc R Soc Med       Date:  1972-04

2.  Management of acute renal failure due to marked hyperuricemia.

Authors:  D Alsarraf; L Reese
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

3.  Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.

Authors:  Manzilat Akande; Anthony N Audino; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

4.  Allopurinol in the treatment of uraemic patients with gout.

Authors:  J D Wilson; H A Simmonds; J D North
Journal:  Ann Rheum Dis       Date:  1967-03       Impact factor: 19.103

5.  Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia.

Authors:  Kristine R Crews; Yinmei Zhou; Jennifer L Pauley; Scott C Howard; Sima Jeha; Mary V Relling; Ching-Hon Pui
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

6.  Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.

Authors:  S J Appelbaum; M Mayersohn; R T Dorr; D Perrier
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells.

Authors:  W N Kelley; J B Wyngaarden
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

8.  The treatment of gout and disorders of uric acid metabolism with allopurinol.

Authors:  M A Ogryzlo; M B Urowitz; H M Weber; J B Houpt
Journal:  Can Med Assoc J       Date:  1966-11-26       Impact factor: 8.262

9.  Prediction of drug efficacy from transcriptional profiles with deep learning.

Authors:  Jie Zhu; Jingxiang Wang; Xin Wang; Mingjing Gao; Bingbing Guo; Miaomiao Gao; Jiarui Liu; Yanqiu Yu; Liang Wang; Weikaixin Kong; Yongpan An; Zurui Liu; Xinpei Sun; Zhuo Huang; Hong Zhou; Ning Zhang; Ruimao Zheng; Zhengwei Xie
Journal:  Nat Biotechnol       Date:  2021-06-17       Impact factor: 54.908

10.  Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies.

Authors:  Leanne D Kennedy; Susannah Koontz; Kamakshi Rao
Journal:  J Blood Med       Date:  2011-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.